{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T09:10:51Z","timestamp":1787735451545,"version":"build-2784847793"},"reference-count":48,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T00:00:00Z","timestamp":1711324800000},"content-version":"vor","delay-in-days":84,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Euregio Science Funds","award":["IPN170"],"award-info":[{"award-number":["IPN170"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Recent reports indicated that myelin oligodendrocyte glycoprotein antibody-associated disease might be a rare complication after severe acute respiratory syndrome coronavirus 2 infection or vaccination. It is unclear whether this is an unspecific sequel of infection or vaccination or caused by possible immunological cross-reactivity of severe acute respiratory syndrome coronavirus 2 proteins and myelin oligodendrocyte glycoprotein. The aim of this study was therefore to elucidate whether there is an immunological cross-reactivity between severe acute respiratory syndrome coronavirus 2 spike or nucleocapsid proteins and myelin oligodendrocyte glycoprotein and to explore the relation of antibody responses against myelin oligodendrocyte glycoprotein and severe acute respiratory syndrome coronavirus 2 and other coronaviruses. We analysed serum samples from patients with severe acute respiratory syndrome coronavirus 2 infection and neurological symptoms with (myelin oligodendrocyte glycoprotein antibody-associated disease, n = 12) or without myelin oligodendrocyte glycoprotein-antibodies (n = 10); severe acute respiratory syndrome coronavirus 2 infection without neurological symptoms (n = 32); vaccinated patients with no history of severe acute respiratory syndrome coronavirus 2 infection and neurological symptoms with (myelin oligodendrocyte glycoprotein antibody-associated disease, n = 10) or without myelin oligodendrocyte glycoprotein-antibodies (n = 9); and severe acute respiratory syndrome coronavirus 2 negative\/na\u00efve unvaccinated patients with neurological symptoms with (myelin oligodendrocyte glycoprotein antibody-associated disease, n = 47) or without myelin oligodendrocyte glycoprotein-antibodies (n = 20). All samples were analysed for serum antibody responses to myelin oligodendrocyte glycoprotein, severe acute respiratory syndrome coronavirus 2, and other common coronaviruses (CoV-229E, CoV-HKU1, CoV-NL63 and CoV-OC43). Based on sample amount and antibody titres, 21 samples were selected for analysis of antibody cross-reactivity between myelin oligodendrocyte glycoprotein and severe acute respiratory syndrome coronavirus 2 spike and nucleocapsid proteins using affinity purification and pre-absorption. Whereas we found no association of immunoglobulin G and A myelin oligodendrocyte glycoprotein antibodies with coronavirus antibodies, infections with severe acute respiratory syndrome coronavirus 2 correlated with an increased immunoglobulin M myelin oligodendrocyte glycoprotein antibody response. Purified antibodies showed no cross-reactivity between severe acute respiratory syndrome coronavirus 2 spike protein and myelin oligodendrocyte glycoprotein. However, one sample of a patient with myelin oligodendrocyte glycoprotein antibody-associated disease following severe acute respiratory syndrome coronavirus 2 infection showed a clear immunoglobulin G antibody cross-reactivity to severe acute respiratory syndrome coronavirus 2 nucleocapsid protein and myelin oligodendrocyte glycoprotein. This patient was also seropositive for other coronaviruses and showed immunological cross-reactivity of severe acute respiratory syndrome coronavirus 2 and CoV-229E nucleocapsid proteins. Overall, our results indicate that an immunoglobulin G antibody cross-reactivity between myelin oligodendrocyte glycoprotein and severe acute respiratory syndrome coronavirus 2 proteins is rare. The presence of increased myelin oligodendrocyte glycoprotein-immunoglobulin M antibodies after severe acute respiratory syndrome coronavirus 2 infection may either be a consequence of a previous infection with other coronaviruses or arise as an unspecific sequel after viral infection. Furthermore, our data indicate that myelin oligodendrocyte glycoprotein-immunoglobulin A and particularly myelin oligodendrocyte glycoprotein-immunoglobulin M antibodies are a rather unspecific sequel of viral infections. Finally, our findings do not support a causative role of coronavirus infections for the presence of myelin oligodendrocyte glycoprotein-immunoglobulin G antibodies.<\/jats:p>","DOI":"10.1093\/braincomms\/fcae106","type":"journal-article","created":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T01:53:14Z","timestamp":1711417994000},"source":"Crossref","is-referenced-by-count":4,"title":["Is there an immunological cross-reactivity of antibodies to the myelin oligodendrocyte glycoprotein and coronaviruses?"],"prefix":"10.1093","volume":"6","author":[{"given":"Kathrin","family":"Schanda","sequence":"first","affiliation":[{"name":"Clinical Department of Neurology, Medical University of Innsbruck , 6020 Innsbruck , Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Mariotto","sequence":"additional","affiliation":[{"name":"Neurology Unit, Department of Neurosciences, Biomedicine, and Movement Sciences, University of Verona , 37100 Verona , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dagmar","family":"Rudzki","sequence":"additional","affiliation":[{"name":"Clinical Department of Neurology, Medical University of Innsbruck , 6020 Innsbruck , Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelika","family":"Bauer","sequence":"additional","affiliation":[{"name":"Institute of Hygiene and Medical Microbiology, Medical University of Innsbruck , 6020 Innsbruck , Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3249-4792","authenticated-orcid":false,"given":"Alessandro","family":"Dinoto","sequence":"additional","affiliation":[{"name":"Neurology Unit, Department of Neurosciences, Biomedicine, and Movement Sciences, University of Verona , 37100 Verona , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Rossi","sequence":"additional","affiliation":[{"name":"Neurology Unit, St Bassiano Hospital , Bassano del Grappa, 36100 Vicenza , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Ferrari","sequence":"additional","affiliation":[{"name":"Neurology Unit, Department of Neurosciences, Biomedicine, and Movement Sciences, University of Verona , 37100 Verona , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"Jarius","sequence":"additional","affiliation":[{"name":"Molecular Neuroimmunology Group, Department of Neurology, University of Heidelberg , 69120 Heidelberg , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Wildemann","sequence":"additional","affiliation":[{"name":"Molecular Neuroimmunology Group, Department of Neurology, University of Heidelberg , 69120 Heidelberg , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Boso","sequence":"additional","affiliation":[{"name":"Neurology Unit, Trento Hospital, Azienda Provinciale per i Servizi Sanitari (APSS) di Trento , 38122 Trento , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Giometto","sequence":"additional","affiliation":[{"name":"Neurology Unit, Trento Hospital, Azienda Provinciale per i Servizi Sanitari (APSS) di Trento , 38122 Trento , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Engels","sequence":"additional","affiliation":[{"name":"Institute of Clinical Neuroimmunology, University Hospital, Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen , 81375 Munich , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7509-5268","authenticated-orcid":false,"given":"Tania","family":"K\u00fcmpfel","sequence":"additional","affiliation":[{"name":"Institute of Clinical Neuroimmunology, University Hospital, Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen , 81375 Munich , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva-Maria","family":"Wendel","sequence":"additional","affiliation":[{"name":"Department of Neuropediatrics, Olgahospital\/Klinikum Stuttgart , 70174 Stuttgart , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Rostasy","sequence":"additional","affiliation":[{"name":"Paediatric Neurology, Witten\/Herdecke University, Children's Hospital Datteln , 45711 Datteln , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2817-1402","authenticated-orcid":false,"given":"Markus","family":"Reindl","sequence":"additional","affiliation":[{"name":"Clinical Department of Neurology, Medical University of Innsbruck , 6020 Innsbruck , Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,3,25]]},"reference":[{"issue":"1","key":"2024043010252717300_fcae106-B1","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.cell.2020.08.028","article-title":"Effects of COVID-19 on the nervous system","volume":"183","author":"Iadecola","year":"2020","journal-title":"Cell"},{"issue":"1","key":"2024043010252717300_fcae106-B2","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12974-021-02339-0","article-title":"Cerebrospinal fluid findings in COVID-19: A multicenter study of 150 lumbar punctures in 127 patients","volume":"19","author":"Jarius","year":"2022","journal-title":"J Neuroinflammation"},{"issue":"6578","key":"2024043010252717300_fcae106-B3","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1126\/science.abm2052","article-title":"Nervous system consequences of COVID-19","volume":"375","author":"Spudich","year":"2022","journal-title":"Science"},{"issue":"9","key":"2024043010252717300_fcae106-B4","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S1474-4422(20)30221-0","article-title":"Neurological associations of COVID-19","volume":"19","author":"Ellul","year":"2020","journal-title":"Lancet Neurol"},{"issue":"12","key":"2024043010252717300_fcae106-B5","doi-asserted-by":"crossref","first-page":"3576","DOI":"10.1093\/brain\/awab302","article-title":"Acute and chronic neurological disorders in COVID-19: Potential mechanisms of disease","volume":"144","author":"Balcom","year":"2021","journal-title":"Brain"},{"issue":"3","key":"2024043010252717300_fcae106-B6","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S1474-4422(22)00431-8","article-title":"Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria","volume":"22","author":"Banwell","year":"2023","journal-title":"Lancet Neurol"},{"issue":"6","key":"2024043010252717300_fcae106-B7","doi-asserted-by":"crossref","first-page":"e1080","DOI":"10.1212\/NXI.0000000000001080","article-title":"Acute disseminated encephalomyelitis and acute hemorrhagic leukoencephalitis following COVID-19: Systematic review and meta-synthesis","volume":"8","author":"Manzano","year":"2021","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"7","key":"2024043010252717300_fcae106-B8","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1177\/13524585211057512","article-title":"MOG-antibody-associated longitudinal extensive myelitis after ChAdOx1 nCoV-19 vaccination","volume":"28","author":"Dams","year":"2022","journal-title":"Mult Scler"},{"key":"2024043010252717300_fcae106-B9","doi-asserted-by":"crossref","first-page":"17562864211070684","DOI":"10.1177\/17562864211070684","article-title":"MOG antibody-associated encephalomyelitis mimicking bacterial meningomyelitis following ChAdOx1 nCoV-19 vaccination: A case report","volume":"15","author":"Escola","year":"2022","journal-title":"Ther Adv Neurol Disord"},{"key":"2024043010252717300_fcae106-B10","doi-asserted-by":"crossref","first-page":"577939","DOI":"10.1016\/j.jneuroim.2022.577939","article-title":"Central nervous system (CNS) inflammatory demyelinating diseases (IDDs) associated with COVID-19: A case series and review","volume":"371","author":"Feizi","year":"2022","journal-title":"J Neuroimmunol"},{"issue":"3","key":"2024043010252717300_fcae106-B11","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S1474-4422(22)00043-6","article-title":"MOG antibody-associated disease after vaccination with ChAdOx1 nCoV-19","volume":"21","author":"Francis","year":"2022","journal-title":"Lancet Neurol"},{"issue":"8","key":"2024043010252717300_fcae106-B12","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.2169\/internalmedicine.8709-21","article-title":"SARS-CoV-2-related myelin oligodendrocyte glycoprotein antibody-associated disease: A case report and literature review","volume":"61","author":"Ide","year":"2022","journal-title":"Intern Med"},{"issue":"10","key":"2024043010252717300_fcae106-B13","doi-asserted-by":"crossref","first-page":"5198","DOI":"10.1007\/s00415-022-11194-9","article-title":"MOG encephalomyelitis after vaccination against severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2): Case report and comprehensive review of the literature","volume":"269","author":"Jarius","year":"2022","journal-title":"J Neurol"},{"issue":"8","key":"2024043010252717300_fcae106-B14","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1002\/acn3.51609","article-title":"SARS-COV-2 a trigger of myelin oligodendrocyte glycoprotein-associated disorder","volume":"9","author":"Johnsson","year":"2022","journal-title":"Ann Clin Transl Neurol"},{"key":"2024043010252717300_fcae106-B15","doi-asserted-by":"crossref","first-page":"104141","DOI":"10.1016\/j.msard.2022.104141","article-title":"Onset of various CNS inflammatory demyelination diseases following COVID-19 vaccinations","volume":"68","author":"Kim","year":"2022","journal-title":"Mult Scler Relat Disord"},{"key":"2024043010252717300_fcae106-B16","doi-asserted-by":"crossref","first-page":"577933","DOI":"10.1016\/j.jneuroim.2022.577933","article-title":"Myelin oligodendrocyte glycoprotein-IgG associated disorders (MOGAD) following SARS-CoV-2 infection: A case series","volume":"370","author":"Lambe","year":"2022","journal-title":"J Neuroimmunol"},{"issue":"6","key":"2024043010252717300_fcae106-B17","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1111\/ene.15304","article-title":"Is there a correlation between MOG-associated disorder and SARS-CoV-2 infection?","volume":"29","author":"Mariotto","year":"2022","journal-title":"Eur J Neurol"},{"key":"2024043010252717300_fcae106-B18","doi-asserted-by":"crossref","first-page":"845755","DOI":"10.3389\/fneur.2022.845755","article-title":"MOG antibody-associated disorders following SARS-CoV-2 vaccination: A case report and literature review","volume":"13","author":"Matsumoto","year":"2022","journal-title":"Front Neurol"},{"key":"2024043010252717300_fcae106-B19","doi-asserted-by":"crossref","first-page":"103739","DOI":"10.1016\/j.msard.2022.103739","article-title":"COVID-19 vaccine associated demyelination & its association with MOG antibody","volume":"60","author":"Netravathi","year":"2022","journal-title":"Mult Scler Relat Disord"},{"issue":"4","key":"2024043010252717300_fcae106-B20","doi-asserted-by":"crossref","first-page":"e200129","DOI":"10.1212\/NXI.0000000000200129","article-title":"Frequency and referral patterns of neural antibody studies during the COVID-19 pandemic: Experience from an autoimmune neurology center","volume":"10","author":"Arino","year":"2023","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"1","key":"2024043010252717300_fcae106-B21","doi-asserted-by":"crossref","first-page":"e200063","DOI":"10.1212\/NXI.0000000000200063","article-title":"Acute inflammatory diseases of the central nervous system after SARS-CoV-2 vaccination","volume":"10","author":"Francis","year":"2023","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"10","key":"2024043010252717300_fcae106-B22","doi-asserted-by":"crossref","first-page":"4292","DOI":"10.1093\/brain\/awad155","article-title":"Neurologic sequelae of COVID-19 are determined by immunologic imprinting from previous coronaviruses","volume":"146","author":"Spatola","year":"2023","journal-title":"Brain"},{"issue":"9","key":"2024043010252717300_fcae106-B23","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/S1474-4422(21)00218-0","article-title":"Myelin-oligodendrocyte glycoprotein antibody-associated disease","volume":"20","author":"Marignier","year":"2021","journal-title":"Lancet Neurol"},{"issue":"1","key":"2024043010252717300_fcae106-B24","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1186\/s12974-016-0718-0","article-title":"MOG-IgG in NMO and related disorders: A multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome","volume":"13","author":"Jarius","year":"2016","journal-title":"J Neuroinflammation"},{"issue":"1","key":"2024043010252717300_fcae106-B25","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s12974-018-1144-2","article-title":"MOG encephalomyelitis: International recommendations on diagnosis and antibody testing","volume":"15","author":"Jarius","year":"2018","journal-title":"J Neuroinflammation"},{"key":"2024043010252717300_fcae106-B26","doi-asserted-by":"crossref","first-page":"104175","DOI":"10.1016\/j.msard.2022.104175","article-title":"Clinical onset of CNS demyelinating disease after COVID-19 vaccination: De novo disease?","volume":"67","author":"Gernert","year":"2022","journal-title":"Mult Scler Relat Disord"},{"key":"2024043010252717300_fcae106-B27","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/1742-2094-8-184","article-title":"Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optical and related disorders","volume":"8","author":"Mader","year":"2011","journal-title":"J Neuroinflammation"},{"issue":"2","key":"2024043010252717300_fcae106-B28","doi-asserted-by":"crossref","first-page":"e674","DOI":"10.1212\/NXI.0000000000000674","article-title":"International multicenter examination of MOG antibody assays","volume":"7","author":"Reindl","year":"2020","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"5","key":"2024043010252717300_fcae106-B29","doi-asserted-by":"crossref","first-page":"e1027","DOI":"10.1212\/NXI.0000000000001027","article-title":"Differential binding of autoantibodies to MOG isoforms in inflammatory demyelinating diseases","volume":"8","author":"Schanda","year":"2021","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"3","key":"2024043010252717300_fcae106-B30","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.cell.2020.09.032","article-title":"Structural and functional analysis of the D614G SARS-CoV-2 spike protein variant","volume":"183","author":"Yurkovetskiy","year":"2020","journal-title":"Cell"},{"issue":"9","key":"2024043010252717300_fcae106-B31","first-page":"S271","article-title":"Increased frequencies of antibodies to native myelin oligodendrocyte glycoprotein in acute demyelinating encephalomyelitis","volume":"15","author":"Di Pauli","year":"2009","journal-title":"Multiple Sclerosis"},{"key":"2024043010252717300_fcae106-B32","doi-asserted-by":"crossref","first-page":"836449","DOI":"10.3389\/fimmu.2022.836449","article-title":"Age-associated seroprevalence of coronavirus antibodies: Population-based serosurveys in 2013 and 2020, British Columbia, Canada","volume":"13","author":"Tanunliong","year":"2022","journal-title":"Front Immunol"},{"issue":"Pt 6","key":"2024043010252717300_fcae106-B33","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1093\/brain\/awg127","article-title":"A new paraclinical CSF marker for hypoxia-like tissue damage in multiple sclerosis lesions","volume":"126","author":"Lassmann","year":"2003","journal-title":"Brain"},{"issue":"2","key":"2024043010252717300_fcae106-B34","doi-asserted-by":"crossref","first-page":"335","DOI":"10.4049\/jimmunol.1801149","article-title":"Original antigenic sin: How first exposure shapes lifelong anti-influenza virus immune responses","volume":"202","author":"Zhang","year":"2019","journal-title":"J Immunol"},{"issue":"10","key":"2024043010252717300_fcae106-B35","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1016\/j.immuni.2022.07.020","article-title":"Antibodies from primary humoral responses modulate the recruitment of naive B cells during secondary responses","volume":"55","author":"Tas","year":"2022","journal-title":"Immunity"},{"issue":"1","key":"2024043010252717300_fcae106-B36","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.chom.2021.12.005","article-title":"Pre-existing humoral immunity to human common cold coronaviruses negatively impacts the protective SARS-CoV-2 antibody response","volume":"30","author":"Lin","year":"2022","journal-title":"Cell Host Microbe"},{"key":"2024043010252717300_fcae106-B37","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.msard.2019.01.007","article-title":"Frequency and relevance of IgM, and IgA antibodies against MOG in MOG-IgG-associated disease","volume":"28","author":"Pedreno","year":"2019","journal-title":"Mult Scler Relat Disord"},{"issue":"9","key":"2024043010252717300_fcae106-B38","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1001\/jamaneurol.2023.2523","article-title":"Immunoglobulin A antibodies against myelin oligodendrocyte glycoprotein in a subgroup of patients with central nervous system demyelination","volume":"80","author":"Ayroza Galvao Ribeiro Gomes","year":"2023","journal-title":"JAMA Neurol"},{"issue":"11","key":"2024043010252717300_fcae106-B39","doi-asserted-by":"crossref","first-page":"4097","DOI":"10.1093\/brain\/awac321","article-title":"Brain injury in COVID-19 is associated with dysregulated innate and adaptive immune responses","volume":"145","author":"Needham","year":"2022","journal-title":"Brain"},{"issue":"6","key":"2024043010252717300_fcae106-B40","doi-asserted-by":"crossref","first-page":"100321","DOI":"10.1016\/j.xcrm.2021.100321","article-title":"Broad auto-reactive IgM responses are common in critically ill patients, including those with COVID-19","volume":"2","author":"Wong","year":"2021","journal-title":"Cell Rep Med"},{"issue":"3","key":"2024043010252717300_fcae106-B41","doi-asserted-by":"crossref","first-page":"e89","DOI":"10.1212\/NXI.0000000000000089","article-title":"MOG cell-based assay detects non-MS patients with inflammatory neurologic disease","volume":"2","author":"Waters","year":"2015","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"2","key":"2024043010252717300_fcae106-B42","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/s41582-018-0112-x","article-title":"Myelin oligodendrocyte glycoprotein antibodies in neurological disease","volume":"15","author":"Reindl","year":"2019","journal-title":"Nat Rev Neurol"},{"issue":"11","key":"2024043010252717300_fcae106-B43","doi-asserted-by":"crossref","first-page":"e1095","DOI":"10.1212\/WNL.0000000000201662","article-title":"Significance of myelin oligodendrocyte glycoprotein antibodies in CSF: A retrospective multicenter study","volume":"100","author":"Carta","year":"2023","journal-title":"Neurology"},{"issue":"9","key":"2024043010252717300_fcae106-B44","doi-asserted-by":"crossref","first-page":"3938","DOI":"10.1093\/brain\/awad122","article-title":"Diagnostic implications of MOG-IgG detection in sera and cerebrospinal fluids","volume":"146","author":"Matsumoto","year":"2023","journal-title":"Brain"},{"issue":"6","key":"2024043010252717300_fcae106-B45","doi-asserted-by":"crossref","first-page":"e200035","DOI":"10.1212\/NXI.0000000000200035","article-title":"Temporal dynamics of MOG antibodies in children with acquired demyelinating syndrome","volume":"9","author":"Wendel","year":"2022","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"1","key":"2024043010252717300_fcae106-B46","doi-asserted-by":"crossref","first-page":"e200183","DOI":"10.1212\/NXI.0000000000200183","article-title":"Timing of MOG-IgG testing is key to 2023 MOGAD diagnostic criteria","volume":"11","author":"Forcadela","year":"2024","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"2024043010252717300_fcae106-B47","doi-asserted-by":"crossref","first-page":"104933","DOI":"10.1016\/j.jcv.2021.104933","article-title":"Stability of SARS-CoV-2 IgG in multiple laboratory conditions and blood sample types","volume":"142","author":"Kanji","year":"2021","journal-title":"J Clin Virol"},{"key":"2024043010252717300_fcae106-B48","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.clinbiochem.2021.06.003","article-title":"Sample stability of autoantibodies: A tool for laboratory quality initiatives","volume":"96","author":"Higgins","year":"2021","journal-title":"Clin Biochem"}],"container-title":["Brain Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/braincomms\/advance-article-pdf\/doi\/10.1093\/braincomms\/fcae106\/57088830\/fcae106.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/braincomms\/article-pdf\/6\/2\/fcae106\/57293269\/fcae106.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/braincomms\/article-pdf\/6\/2\/fcae106\/57293269\/fcae106.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T10:26:34Z","timestamp":1714472794000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/braincomms\/article\/doi\/10.1093\/braincomms\/fcae106\/7634794"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,3,1]]}},"URL":"https:\/\/doi.org\/10.1093\/braincomms\/fcae106","relation":{},"ISSN":["2632-1297"],"issn-type":[{"value":"2632-1297","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024]]},"published":{"date-parts":[[2024]]},"article-number":"fcae106"}}